Skip to Content

THC Therapeutics Inc THCT Stock Quote

| Rating as of

Morningstar‘s Stock Analysis THCT

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics THCT

Company Profile THCT

Business Description

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours while reducing the viability of microbial contaminants.

Contact
11700 W Charleston Bpulevard, Suite 73
Las Vegas, NV, 89135
T +1 833 420-8428
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Apr 30, 2022
Fiscal Year End Jul 31, 2022
Stock Type Distressed
Employees 1